Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | COL6A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | STARD6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | GLMP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ANKRD63 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SEC14L4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | MAPT | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SULT4A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | FADS2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ARL17B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | HRH1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |